InsidersTradesSigma
Explore the complete record of transactions filed by Franson Timothy R, Director. Director active across 2 companies, notably Cidara Therapeutics, Inc.. In total, 4 disclosures have been logged. Total volume traded: €25k. The latest transaction was disclosed on 16 February 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
4 of 4 declarations
Timothy R. Franson is a Board Member at Cidara Therapeutics, Inc. and Paratek Pharmaceuticals, Inc. He brings his expertise to the board, contributing to strategic decision-making for these companies. His role includes overseeing operations and protecting shareholder interests. Through his experience, he helps guide the future direction of the companies.